A Study of HR19024 in Subjects With Advanced Solid Tumor
Status:
Not yet recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety，tolerability，pharmacokinetic characteristics and preliminary efficacy
of HR19024 injection in the treatment of advanced solid tumor